Autolus Therapeutics announces publication in ACS Chemical B

LONDON, Jan. 23, 2024 -- Autolus Therapeutics plc , a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced a publication in ACS Chemical...

Related Keywords

London , City Of , United Kingdom , Olivia Manser , Julia Wilson , Susana Noonan , Lauren Williams , Exchange Commission On , Exchange Commission , Sa Noonan Communications , Nasdaq , Chief Scientific Officer , Small Molecule Control System Based , Minocycline Induced Disruption , Rapamycin Activated Caspase , Based Suicide , Autolus Therapeutics , Private Securities Litigation Reform Act , Autolu Annual Report , Markets ,